Is CBD Legal in Colorado? Colorado Cannabis, Hemp, and CBD Laws (2026)

Colorado permits qualifying hemp CBD products and CBD-containing products within its licensed marijuana system. These are different regulatory routes, and neither means that every product marketed as CBD is lawful. Composition, serving size, intended use, licensing, and age requirements all matter.

Hemp is also not a guarantee of non-intoxication. A percentage threshold does not tell you how many milligrams of THC are in an entire package. Colorado’s Department of Transportation warns that hemp products can contain intoxicating ingredients. Our U.S. CBD guide explains the additional federal rules.

Hemp CBD and Marijuana Products

Hemp-derived CBD can qualify for the federal hemp exemption from control as marijuana. The current federal definition uses no more than 0.3% delta-9 THC on a dry-weight basis, but that exemption does not authorize every finished product or its marketing.

Products regulated as marijuana are sold through Colorado’s licensed marijuana system. Adult-use customers must be 21 or older. Registered medical patients have a separate route, including eligible younger patients subject to additional requirements. It is therefore inaccurate to describe marijuana-derived CBD as available only to adults 21 and older.

The CBD molecule does not reveal which rules a bottle must meet. A product’s source, other cannabinoids, manufacturing method, and intended use also matter. “Full-spectrum” or “isolate” branding cannot replace that assessment.

Colorado’s Hemp Regulators

The Colorado Department of Agriculture administers hemp cultivation. Finished hemp products fall under separate public-health requirements, including facility registration, sourcing, laboratory testing, and labeling.

Senate Bill 23-271 expanded Colorado’s regulation of hemp products and distinguishes non-intoxicating, potentially intoxicating, and intoxicating cannabinoids. The implementing rules, 6 CCR 1010-24, govern hemp-product and export-oriented safe-harbor manufacturing.

A safe-harbor registration allows specified production for export; it does not authorize selling those products to Colorado consumers or shipping them to a state that prohibits them. Nor does a marijuana license automatically authorize any synthetic or converted cannabinoid. Applicable manufacturing and product rules must be satisfied.

THC Serving Limits and CBD-to-THC Ratios

The hemp manufacturing rules prohibit products with more than 1.75 mg total THC per serving and products with a CBD-to-THC ratio below 15:1. Those provisions are distinct from the 1.25 mg and 20:1 thresholds used in age and package restrictions.

For example, 1 mg of THC combined with 20 mg of CBD gives a 20:1 ratio. A ratio says how the cannabinoid quantities compare; it does not erase the THC or demonstrate that a particular person will experience no effects.

The rules also restrict synthetic cannabinoids and chemical conversion into intoxicating compounds. A low delta-9 THC result does not make a converted intoxicant an ordinary lawful hemp ingredient. Check the complete cannabinoid profile and manufacturing requirements.

Purchase Age and Package Limits

Under Section 25-5-427(8), enacted through SB 23-271, covered hemp products cannot be sold to someone under 21 if they contain more than 1.25 mg THC per serving or have a CBD-to-THC ratio below 20:1. The statute lists exceptions for products with no THC, tinctures, cosmetics, and FDA-recognized GRAS products.

The statutory age rule uses “or”; it should not be reduced to a requirement that both conditions occur together. Retailers can also impose stricter purchasing policies. An exception from this particular restriction does not establish that a product is safe for children or satisfies every other applicable rule.

For covered products above 1.25 mg THC per serving, the statute limits packages to five servings when the CBD-to-THC ratio is below 20:1 and to thirty servings when it is 20:1 or greater, subject to listed exceptions. Manufacturers must also meet the administrative rules. Businesses should resolve the complete statutory and regulatory requirements before choosing package sizes.

The Proposed 10 mg Beverage Bill Did Not Pass

SB 26-164 proposed a new framework for hemp-derived THC beverages with up to 10 mg total THC per serving, including permits linked to alcohol licensees. The Senate Finance Committee postponed it indefinitely on April 28, 2026, and the legislature records its status as lost.

Its proposed higher limit is not an enacted retail allowance. A bill summary describing what the proposal would have done should not be used as a statement of current Colorado CBD or hemp law.

Federal Hemp Changes Have Two Deadlines

Section 781 of Public Law 119-37 narrows the federal hemp definition. The September 2026 extension in Section 2019 delays most amendments until December 11, 2026. November 12 remains the start for exclusions covering intermediate and final products containing cannabinoids that the cannabis plant cannot naturally produce.

The deferred provisions include a total-THC definition counting THCA, exclusions for naturally producible cannabinoids synthesized or manufactured outside the plant, and exclusion of finished products above 0.4 mg per container of combined total THC and specified similarly acting cannabinoids. This is a container threshold, not a serving limit or a cap on CBD itself.

A full-spectrum formulation can be affected even if it meets Colorado’s existing serving and ratio rules. Losing the federal hemp exemption does not automatically make a product lawful through a marijuana store. Colorado’s existing requirements remain applicable during the federal extension.

FDA Rules and Prescription CBD

The FDA prohibits marketing CBD as a dietary supplement and generally prohibits introducing foods with added CBD into interstate commerce. Colorado’s state framework does not waive those restrictions. Calling this merely a federal gray area understates the agency’s explicit position.

Epidiolex is FDA-approved cannabidiol medicine for specified seizure disorders. Its approval does not extend to other retail oils or gummies. Colorado’s medical marijuana registration process is separate from prescribing an approved medicine. The legislature’s marijuana handbook explains additional physician and parent requirements for patients under 18.

The April 28, 2026 federal rule places covered FDA-approved marijuana medicines and state-licensed medical marijuana in Schedule III, while retaining registration and other controls. It does not remove state medical-program requirements or approve every dispensary product as a medicine.

Choosing a Seller and Checking a Product

For marijuana products, verify the retailer through the Marijuana Enforcement Division’s licensing resources. For hemp products, check the manufacturer’s applicable registration and the exact formulation’s compliance. Online availability or a national brand’s shipping policy is not a legal determination.

Match the batch number to a recent certificate of analysis and read total THC per serving, total THC per package, and the CBD-to-THC ratio. Also examine relevant contaminant testing. A label describing a product as non-intoxicating does not replace those checks or establish suitability for driving.

The supplier listings below can help with product research, but each item must be assessed separately. Neither a supplier listing nor a laboratory report authorizes a prohibited food use or unapproved medical claim.